跳至主要内容
临床试验/NCT03786523
NCT03786523已完成不适用

Effects of Time-Restricted Feeding on Nonalcoholic Fatty Liver Disease in Obese Adults: a Randomized Clinical Trial

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2019年4月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
1
主要终点
Change in intrahepatic fat content

研究概览

简要总结

Time restricted feeding (TRF) is a novel type of intermittent calorie restriction diet that involves eating a daily period of 8 hours or less. This is a randomized controlled trial to evaluate the effect of time restricted feeding (TRF) on hepatic fat contents and cardiometabolic risk factors in obese adults over 6 months compared to continuous energy restriction (CER).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or women aged≥18 years;
  • Subjects with NAFLD determined by MRI (intrahepatic triglyceride content ≥5%);
  • Body mass index (BMI)of 28.0 to 45.0 kg/m2;

排除标准

  • History of alcoholic liver disease, chronic viral hepatitis, drug-induced hepatitis, autoimmune hepatitis, cirrhosis, and liver cancer;
  • History of HIV, or active pulmonary tuberculosis;
  • Diagnosis of type 1 and type 2 diabetes;
  • History of malignant tumors;
  • Serious liver dysfunction or chronic kidney disease (AST or ALT > 3 times the upper limit of normal, or eGFR<30 ml/min/1.73 m2);
  • Significant alcohol consumption in the past six months (Consumed more than 20 g/day for women or 30 g/day for men);
  • History of serious cardiovascular or cerebrovascular disease (angina, myocardial infarction or stroke) in the past 6 months;
  • History of severe gastrointestinal diseases or gastrointestinal surgery in the past 12 months;
  • History of Cushing's syndrome, hypothyroidism, acromegaly, hypothalamic obesity;
  • Being a smoker or having been a smoker in the 3 months prior to their screening visit;
  • Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician;
  • Currently participating in weight loss programs or weight change in the past 3 months (> 5% current body weight) ;
  • Women who are pregnant or plan to become pregnant;
  • Patients who cannot be followed for 24 months (due to a health situation or migration);
  • Patients who are unwilling or unable to give informed consent.

结局指标

主要结局

Change in intrahepatic fat content

时间窗: Baseline and months 6

Intrahepatic fat content will be assessed by MR mDixon-Quant

次要结局

  • Change in body fat(Baseline and months 6)
  • Change in HbA1c level(Baseline and months 6)
  • Change in insulin sensitivity(Baseline and months 6)
  • Change in liver fiber(Baseline and months 6)
  • Change in visceral fat(Baseline and months 6)
  • Change in waist circumference(Baseline and months 6)
  • Change in body weight(Baseline and months 6)
  • Change in Systolic blood pressure(Baseline and months 6)
  • Change in LDL-c level(Baseline and months 6)
  • Change in serum ALT level(Baseline and months 6)
  • Change in pulse wave velocity (PWV)(Baseline and months 6)
  • Depression measured by the Patient Health Questionnaire-9 (PHQ-9)(Baseline and months 6)
  • Quality of sleep measured by the Pittsburgh sleep quality index (PSQI)(Baseline and months 6)
  • Change in β cell function(Baseline and months 6)
  • Quality of life measured by the 12-item Short-Form Health Survey Questionnaire (SF-12)(Baseline and months 6)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Time Restricted Feeding on Nonalcoholic Fatty Liver... | 临床试验